Back to GetFilings.com



Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON D.C. 20549

 


 

FORM 10-Q

 


 

x QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

For the quarterly period ended March 31, 2005

 

Commission file number 1-71

 


 

LOGO

 


 

New Jersey   13-0511250

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

180 East Broad Street, Columbus, Ohio 43215

(Address of principal executive offices)

 

(614) 225-4000

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

 


 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.    Yes  ¨    No  x

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

 

Number of shares of common stock, $0.01 par value, outstanding as of the close of business on May 10, 2005: 96,905,936

 



Table of Contents

BORDEN CHEMICAL, INC.

 

INDEX

 

PART I – FINANCIAL INFORMATION

    

Item 1. Borden Chemical, Inc. Condensed Consolidated Financial Statements

    

    Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income, three months ended March 31, 2005 and 2004

   3

    Condensed Consolidated Balance Sheets, March 31, 2005 and December 31, 2004

   4

    Condensed Consolidated Statements of Cash Flows, three months ended March 31, 2005 and 2004

   6

    Condensed Consolidated Statement of Shareholder’s Deficit, three months ended March 31, 2005

   7

    Notes to Condensed Consolidated Financial Statements

   8

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

   27

Item 3. Quantitative and Qualitative Disclosures about Market Risk

   36

Item 4. Controls and Procedures

   36

PART II – OTHER INFORMATION

    

Item 1. Legal Proceedings

   36

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

   36

Item 3. Defaults upon Senior Securities

   36

Item 4. Submission of Matters to a Vote of Security Holders

   36

Item 5. Other Information

   36

Item 6. Exhibits

   37

 

2


Table of Contents

PART 1

 

Item 1. Borden Chemical, Inc. Condensed Consolidated Financial Statements

 

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE (LOSS) INCOME (Unaudited)

BORDEN CHEMICAL, INC.

 

(In thousands, except per share data)


   Three Months ended
March 31,


   2005

    2004

Net sales

   $ 485,166     $ 385,434

Cost of goods sold

     395,309       310,249
    


 

Gross margin

     89,857       75,185
    


 

Distribution expense

     21,345       17,328

Marketing expense

     11,959       11,403

General & administrative expense

     23,745       22,874

Transaction related costs (see Note 1)

     1,500       —  

Business realignment and impairments (income) expense

     (382 )     1,494

Other operating (income) expense

     (279 )     1,284
    


 

Operating income

     31,969       20,802
    


 

Interest expense

     21,785       11,890

Other non-operating expense

     9,113       61
    


 

Income before income tax

     1,071       8,851

Income tax expense

     5,333       3,937
    


 

Net (loss) income

   $ (4,262 )   $ 4,914
    


 

Comprehensive (loss) income

   $ (6,327 )   $ 5,638
    


 

Basic and Diluted Per Share Data

              

Net (loss) income - basic and diluted

   $ (0.04 )   $ 0.02
    


 

Average number of common shares outstanding during the period – basic

     96,906       199,308

Average number of common shares outstanding during the period – diluted

     96,906       200,449

 

See Notes to Condensed Consolidated Financial Statements

 

3


Table of Contents

CONDENSED CONSOLIDATED BALANCE SHEETS

BORDEN CHEMICAL, INC. (Unaudited)

 

(In thousands)

 

ASSETS


   March 31,
2005


   

December 31,

2004


 

Current Assets

                

Cash and equivalents

   $ 124,308     $ 122,111  

Accounts receivable (less allowance for doubtful accounts of $9,754 in 2005 and $10,197 in 2004)

     217,618       226,235  

Inventories:

                

Finished and in-process goods

     54,008       55,656  

Raw materials and supplies

     51,241       54,768  

Other current assets

     16,288       22,991  
    


 


       463,463       481,761  
    


 


Other Assets

     62,327       53,314  

Property and Equipment

                

Land

     33,174       32,945  

Buildings

     103,493       103,504  

Machinery and equipment

     734,833       733,285  
    


 


       871,500       869,734  

Less accumulated depreciation

     (430,736 )     (421,728 )
    


 


       440,764       448,006  

Goodwill

     50,455       50,682  

Other Intangible Assets

     9,897       10,351  
    


 


Total Assets

   $ 1,026,906     $ 1,044,114  
    


 


 

See Notes to Condensed Consolidated Financial Statements

 

4


Table of Contents

CONDENSED CONSOLIDATED BALANCE SHEETS

BORDEN CHEMICAL, INC. (Unaudited)

 

(In thousands, except share data)

 

LIABILITIES AND SHAREHOLDER’S DEFICIT


   March 31,
2005


    December 31,
2004


 

Current Liabilities

                

Accounts and drafts payable

   $ 208,316     $ 222,173  

Debt payable within one year

     8,181       11,588  

Income taxes payable

     33,616       31,556  

Interest payable

     15,956       26,022  

Other current liabilities

     92,426       74,417  
    


 


       358,495       365,756  
    


 


Other Liabilities

                

Long-term debt

     955,157       955,816  

Non-pension post-employment benefit obligations

     110,824       114,502  

Other long-term liabilities

     157,341       156,865  
    


 


       1,223,322       1,227,183  
    


 


Commitments and Contingencies (See Note 8)

                

Shareholder’s Deficit

                

Common stock - $0.01 par value: authorized 300,000,000 shares, Issued 200,167,297, treasury 103,261,361, outstanding 96,905,936 shares in 2005 and 2004

     969       969  

Paid-in capital

     1,286,743       1,274,358  

Treasury stock

     (295,881 )     (295,881 )

Receivable from parent

     (572,816 )     (560,672 )

Accumulated other comprehensive loss

     (109,558 )     (107,493 )

Accumulated deficit

     (864,368 )     (860,106 )
    


 


       (554,911 )     (548,825 )
    


 


Total Liabilities and Shareholder’s Deficit

   $ 1,026,906     $ 1,044,114  
    


 


See Notes to Condensed Consolidated Financial Statements

 

5


Table of Contents

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

BORDEN CHEMICAL, INC.

 

(In thousands)


   Three months ended
March 31,


 
   2005

    2004

 

Cash Flows from (used in) Operating Activities

                

Net (loss) income

   $ (4,262 )   $ 4,914  

Adjustments to reconcile net (loss) income to net cash from (used in) operating activities:

                

Depreciation and amortization

     12,360       11,943  

Unrealized loss (gain) on derivative instruments

     9,809       (145 )

Business realignment and impairments (income) expense

     (382 )     1,494  

Gain on sale of venture interest

     (1,614 )     —    

Deferred tax expense (benefit)

     908       (1,362 )

Other non-cash adjustments

     (10 )     981  

Net change in assets and liabilities:

                

Accounts receivable

     8,323       (3,613 )

Inventories

     4,930       2,238  

Accounts and drafts payable

     (13,526 )     15,986  

Income taxes

     2,126       (1,025 )

Other assets

     6,609       (8,034 )

Other liabilities

     (13,099 )     (17,546 )
    


 


       12,172       5,831  
    


 


Cash Flows (used in) from Investing Activities

                

Capital expenditures

     (6,481 )     (7,471 )

Deferred acquisition costs (see Note 1)

     (9,128 )     —    

Proceeds from the sale of venture interest

     2,507       —    

Proceeds from the sale of assets

     —         8,105  
    


 


       (13,102 )     634  
    


 


Cash Flows (used in) from Financing Activities

                

Net short-term debt repayments

     (3,407 )     (3,026 )

Borrowings of long-term debt

     —         3,028  

Repayments of long-term debt

     (663 )     —    

Purchase price adjustment payable to parent (see Note 5)

     7,500          

Affiliated loan repayments

     —         (4,960 )
    


 


       3,430       (4,958 )
    


 


Effect of exchange rates on cash

     (303 )     (37 )

Increase in cash and equivalents

     2,197       1,470  

Cash and equivalents at beginning of period

     122,111       28,162  
    


 


Cash and equivalents at end of period

   $ 124,308     $ 29,632  
    


 


Supplemental Disclosures of Cash Flow Information

                

Cash paid:

                

Interest, net

   $ 31,497     $ 16,125  

Income taxes, net

     2,299       6,324  

Non-cash activity:

                

Capital contribution by parent

     —         4,250  

 

See Notes to Condensed Consolidated Financial Statements

 

6


Table of Contents

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDER’S DEFICIT (Unaudited)

BORDEN CHEMICAL, INC.

 

(In thousands)

 

     Common
Stock


   Paid-in
Capital


   Treasury
Stock


    Receivable
from
Parent


    Accumulated
Other
Comprehensive
Loss


    Accumulated
Deficit


    Total

 

Balance, December 31, 2004

   $ 969    $ 1,274,358    $ (295,881 )   $ (560,672 )   $ (107,493 )   $ (860,106 )   $ (548,825 )
    

  

  


 


 


 


 


Net loss

                                           (4,262 )     (4,262 )

Translation adjustments

                                   (2,065 )             (2,065 )
                                                  


Comprehensive loss

                                                   (6,327 )
                                                  


Interest accrued on notes from parent

            12,144              (12,144 )                     —    

Compensation expense on BHI Acquisition deferred compensation plan

            241                                      241  
    

  

  


 


 


 


 


Balance, March 31, 2005

   $ 969    $ 1,286,743    $ (295,881 )   $ (572,816 )   $ (109,558 )   $ (864,368 )   $ (554,911 )
    

  

  


 


 


 


 


 

See Notes to Condensed Consolidated Financial Statements

 

7


Table of Contents

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in thousands, except per share amounts and as otherwise indicated)

 

1. Background and Nature of Operations

 

Borden Chemical, Inc. (the “Company”) was incorporated on April 24, 1899. The Company is engaged primarily in manufacturing, processing, purchasing and distributing forest products and industrial resins, formaldehyde, oilfield products, UV coatings and other specialty and industrial chemicals worldwide. Production facilities are located throughout the U.S. and in many foreign countries.

 

In the third quarter of 2004, the Company was acquired by an affiliate of Apollo Management, L.P. (“Apollo”). The Company’s immediate parent is BHI Acquisition Corp. (“BHI Acquisition”), which is a wholly owned subsidiary of BHI Investment LLC, an entity controlled by Apollo. The transactions related to the acquisition of the Company by Apollo are referred to collectively as the “Apollo Transaction”.

 

Prior to the Apollo Transaction, the Company was controlled by an affiliate of Kohlberg Kravis Roberts & Co. (“KKR”) since 1995.

 

The Company has three reportable segments: Forest Products, Performance Resins and International. See Note 10.

 

The Company has incurred approximately $9,100 of direct costs in connection with the Bakelite Acquisition (see Note 12), during the three months ended March 31, 2005, primarily for accounting and legal fees. In accordance with Statement of Financial Accounting Standards (“SFAS”) No. 141, “Business Combinations,” these amounts will be capitalized as part of the purchase price of the acquisition. Accordingly, these direct costs have been deferred on the March 31, 2005 Condensed Consolidated Balance Sheet in Other assets.

 

In addition, the Company has incurred costs totaling approximately $1,500 in connection with the Hexion Combination (see Note 12), during the three months ended March 31, 2005, primarily for accounting and legal fees. As this transaction is considered a merger of entities under common control, in accordance with SFAS 141, these costs have been expensed as incurred and are included in the 2005 Condensed Consolidated Statement of Operations as Transaction related costs.

 

2. Basis of Presentation

 

The accompanying unaudited Condensed Consolidated Financial Statements include the accounts of Borden Chemical, Inc. and its subsidiaries after elimination of intercompany accounts and transactions and contain all adjustments (which, except as otherwise noted, are of a normal, recurring nature), which in the opinion of management are necessary for a fair presentation of the results for the interim periods. Results for the interim periods are not necessarily indicative of results for the full year.

 

Stock-Based Compensation – Effective January 1, 2005, the Company elected to adopt SFAS No. 123(R) (revised 2004), “Share-Based Payment.” Under the provisions of SFAS No. 123(R), stock-based compensation cost is measured at the grant date based on the value of the award and is recognized as expense over the vesting period. As the Company is considered a nonpublic entity that used the minimum value method for pro forma disclosures under SFAS No. 123, “Accounting for Stock-Based Compensation,” the Company is required to apply the prospective transition method. As such, the Company applies the statement to any new awards and to any awards modified, repurchased or cancelled since January 1, 2005. The Company will continue to account for awards outstanding at January 1, 2005 using the accounting principles originally applied to those awards, Accounting Principles Board Opinion No. 25, “Accounting for Stock Issued to Employees.” The adoption of SFAS No. 123(R) had no effect on the Company’s financial condition and results of operations. There were no new awards, award modifications, repurchases or cancellations during the three months ended March 31, 2005.

 

Earnings Per Share – Basic and diluted net (loss) income per share is computed by dividing net (loss) income by the weighted average number of common shares outstanding during the period including the effect of dilutive options, when applicable. The Company had no potentially dilutive instruments outstanding at March 31, 2005. At March 31, 2004, 5,657,930 options to purchase common shares of the Company were outstanding, of which 1,492,000 were considered dilutive. In addition, there were 1,587,301 shares of unvested restricted stock outstanding, which were dilutive.

 

8


Table of Contents

The Company’s diluted EPS is calculated as follows:

 

     2005

    2004

Net (loss) income applicable to common shareholders

   $ (4,262 )   $ 4,914
    


 

Average shares outstanding (in thousands) -basic

     96,906       199,308

Effect of dilutive options (in thousands)

     —         1,141
    


 

Average shares outstanding (in thousands) - diluted

     96,906       200,449
    


 

Diluted EPS

   $ (0.04 )   $ 0.02
    


 

 

Reclassification – The Company has reclassified reported amounts on the 2004 Condensed Consolidated Statement of Operations from Cost of goods sold to General & administrative expense and Distribution expense to conform with the current year presentation. The reclassification increased Cost of goods sold by $712 and decreased General & administrative expense and Distribution expense by $535 and $177, respectively.

 

3. Sale of Venture Interest

 

In 2001, the Company merged its North American foundry resins and coatings businesses with similar businesses of Delta-HA, Inc. (“Delta”) to form HA-International, LLC (“HAI”), in which the Company had a 75% interest at that time. The Limited Liability Agreement of HAI provides Delta the right to purchase between 3-5% of additional interest in HAI each year, beginning in 2004. Delta is limited to acquiring a maximum of 25% of additional interest in HAI under this arrangement. Pursuant to this provision, Delta has purchased a 10% interest in HAI from the Company, 5% during the third quarter of 2004 and 5% during the first quarter 2005, reducing the Company’s interest in HAI to 65%.

 

Delta’s purchase price of the interest is based on the enterprise value of HAI determined by applying a contractually agreed upon multiple to EBITDA, as defined in the agreement. The Company received cash proceeds of $2,507, as determined by the agreement, and recorded a gain of $1,614 related to the sale, which is included in Other operating (income) expense in the 2005 Condensed Consolidated Statement of Operations.

 

4. Business Realignment

 

In June 2003, the Company initiated a realignment program (the “2003 realignment program”) designed to reduce operating expenses and increase organizational efficiency. The components of this program include reducing headcount, streamlining processes, consolidating manufacturing processes and reducing general and administrative expenses. We expect to complete this program in 2005 and will incur additional expenses through its completion. In addition, we have certain additional long-term realignment programs initiated prior to 2003 (the “prior years’ programs”), which primarily relate to consolidation of plant facilities.

 

Three months ended March 31, 2005

 

In the first quarter of 2005, the Company recorded business realignment and impairments income of $382, consisting of plant closure costs (which include plant employee severance and plant asset impairments) of $527 and other severance costs of $96 offset by a gain on the sale of assets of $1,005.

 

Plant Closure Costs

 

Plant closure costs in the first quarter of 2005 include $365 for the 2003 realignment program and $162 for prior years’ programs. The 2003 realignment program expense of $365 relates primarily to costs associated with a plant closing due to changes in the Company’s manufacturing footprint and with the transition of manufacturing from the Company’s North Bay, Ontario plant to another facility. Costs relating to prior years’ programs include environmental remediation of $71 for closed plants in Brazil and other plant closure costs of $91.

 

Other Severance Costs

 

The other severance costs incurred by the Company in the first quarter of 2005 were for workforce reductions related to the 2003 realignment program.

 

9


Table of Contents

Gain on the Sale of Assets

 

In a prior year, the Company recorded an impairment charge on certain assets of its U.K. business, based on the assets’ net realizable value under a pending transaction. Although this transaction did not occur, the Company subsequently sold a portion of these assets in the first quarter of 2005 and recognized a gain of $1,005.

 

Provided below is a rollforward of the business realignment reserves for the first quarter of 2005.

 

     Reserves
December 31,
2004


   2005
Expense


   2005
Settlements/
Charges


    Reserves
March 31,
2005


Plant closure costs

                            

2003 realignment program

   $ 238    $ 365    $ (166 )   $ 437

Prior years’ programs

     3,656      162      (791 )     3,027

Other severance costs

                            

2003 realignment program

     646      96      (191 )     551
    

  

  


 

     $ 4,540    $ 623    $ (1,148 )   $ 4,015
    

  

  


 

 

Three months ended March 31, 2004

 

In the first quarter of 2004, the Company recorded business realignment expense of $1,494, consisting of plant closure costs (which include plant employee severance and plant asset impairments) of $757 and other severance and employee costs of $737.

 

Plant Closure Costs

 

Plant closure costs in the first quarter of 2004 include $331 for the 2003 realignment program and $426 for prior years’ programs. The 2003 realignment program expense of $331 relates primarily to the conversion of the Company’s manufacturing facility in France to a distribution center and the transition of the related manufacturing to the U.K. Costs relating to prior years’ programs include environmental remediation of $238 for closed plants in Brazil and other plant closure costs of $188.

 

Other Severance Costs

 

The other severance costs incurred by the Company in the first quarter of 2004 were for workforce reductions related to the 2003 realignment program.

 

Provided below is a rollforward of the business realignment reserves for the first quarter of 2004.

 

     Reserves
December 31,
2003


   2004
Expense


   2004
Settlements/
Charges


    Reserves
March 31,
2004


Plant closure costs

                            

2003 realignment program

   $ 3,488    $ 331    $ (1,833 )   $ 1,986

Prior years’ programs

     4,741      426      (563 )     4,604

Other severance costs

                            

2003 realignment program

     2,784      737      (536 )     2,985

Prior years’ programs

     1,151      —        (1,151 )     —  
    

  

  


 

     $ 12,164    $ 1,494    $ (4,083 )   $ 9,575
    

  

  


 

 

10


Table of Contents

5. Related Party Transactions

 

Administrative Service, Management and Consulting Arrangements

 

In connection with the Apollo Transaction, the Company entered into a transaction fee agreement with Apollo and its affiliates for the provision of certain structuring and advisory services. The agreement allows Apollo and its affiliates to provide certain advisory services to the Company for a seven-year period, with an automatic extension of the term for a one-year period beginning on the fourth anniversary of the commencement of the agreement and at the end of each year thereafter, unless notice to the contrary is given by either party. Under the agreement, the Company has also agreed to indemnify Apollo and its affiliates and their directors, officers and representatives for potential losses relating to the services contemplated under this agreement. The agreement, as later supplemented, provides for an annual fee of $2,500 for each annual period after January 1, 2005. The Company has paid the $2,500 annual fee for 2005. In the first quarter of 2005, the Company expensed $625 of fees pursuant to the agreement. The remaining $1,875 is included in Other current assets on the Condensed Consolidated Balance Sheet at March 31, 2005.

 

Prior to the Apollo Transaction, KKR provided certain management, consulting and board services to the Company for an annual fixed fee. During the quarter ended March 31, 2004, the Company recorded fees of $750 for the amount due to KKR under this arrangement.

 

Prior to the Apollo Transaction, the Company provided certain administrative services to BW Holdings, LLC, a former affiliate, and other former affiliates under a service agreement. For the three months ended March 31, 2004, the Company charged these former affiliates $122 for these services.

 

Other Transactions and Arrangements

 

The Company sells finished goods to certain Apollo affiliates. These sales totaled $1,936 for the three months ended March 31, 2005. Accounts receivable from these Apollo affiliates totaled $1,549 at March 31, 2005. In addition, the Company purchases finished goods from certain Apollo affiliates. These purchases totaled $569 for the three months ended March 31, 2005. Accounts payable to these Apollo affiliates totaled $123 at March 31, 2005.

 

In the first quarter of 2005, the Company received a payment of $7,500 from KKR for adjustments made to the purchase price of the Company in the Apollo Transaction. As the Company will pay this amount to BHI Acquisition in the second quarter of 2005, the balance is included in Other current liabilities on the Condensed Consolidated Balance Sheet at March 31, 2005

 

Prior to the Apollo Transaction, the Company utilized Willis Group Holdings, Ltd. (“Willis”), an entity controlled by KKR, as its insurance broker. In the first quarter of 2004, the Company paid $405 to Willis for their services.

 

6. Deal Contingent Forward

 

On December 14, 2004, the Company entered into a foreign currency forward position of $235 million to purchase Euros with U.S. Dollars at a rate of 1.3430. The contract was contingent upon the close of the Bakelite Aktiengesellschaft (“Bakelite”) share purchase agreement (see Note 12). On March 31, 2005, the Company adjusted the contract to have a target settlement date of April 29, 2005 and a new foreign exchange rate of 1.3446. The purpose of the forward was to mitigate the risk of foreign currency exposure related to the transaction. At March 31, 2005, the Company recorded an unrealized loss of $10,432 related to the contingent forward contract, which is included as Other non-operating expense in the 2005 Condensed Consolidated Statement of Operations. On April 29, 2005, upon the close of the Bakelite share purchase agreement, the Company recorded a realized loss of approximately $9,200.

 

7. Guarantees, Indemnifications and Warranties

 

Standard Guarantees / Indemnifications

 

In the ordinary course of business, the Company enters into numerous agreements that contain standard guarantees and indemnities whereby the Company indemnifies another party for, among other things, breaches of representations and warranties. Such guarantees or indemnifications are granted under various agreements, including those governing (i) purchases and sales of assets or businesses, (ii) leases of real property, (iii) licenses of intellectual property and (iv) long-term supply agreements. The guarantees or indemnifications issued are for the benefit of the (i) buyers in sale agreements and sellers in purchase agreements, (ii) landlords or lessors in lease contracts, (iii) licensors or licensees in license agreements and (iv) vendors or customers in long-term supply agreements.

 

11


Table of Contents

These parties may also be indemnified against any third party claim resulting from the transaction that is contemplated in the underlying agreement. Additionally, in connection with the sale of assets and the divestiture of businesses, the Company may agree to indemnify the buyer with respect to liabilities related to the pre-closing operations of the assets or businesses sold. Indemnities related to pre-closing operations generally include tax liabilities, environmental liabilities and employee benefit liabilities not assumed by the buyer in the transaction.

 

Indemnities related to the pre-closing operations of sold assets normally do not represent additional liabilities to the Company, but simply serve to protect the buyer from potential liability associated with the Company’s existing obligations at the time of sale. As with any liability, the Company has accrued for those pre-closing obligations that are considered probable and reasonably estimable. Amounts recorded are not significant at March 31, 2005.

 

While some of these guarantees extend only for the duration of the underlying agreement, many survive the expiration of the term of the agreement or extend into perpetuity (unless subject to a legal statute of limitations). There are no specific limitations on the maximum potential amount of future payments that the Company could be required to make under these guarantees nor is the Company able to develop an estimate of the maximum potential amount of future payments to be made under these guarantees as the triggering events are not predictable. With respect to certain of the aforementioned guarantees, the Company maintains limited insurance coverage that mitigates potential payments to be made. The Company had limited reimbursement agreements from affiliates that were terminated as a result of the Apollo Transaction.

 

In connection with the Apollo Transaction, the Company entered into a transaction fee agreement with Apollo and its affiliates for the provision of certain structuring and advisory services. The Company has agreed to indemnify Apollo and its affiliates and their directors, officers and representatives for potential losses relating to the services contemplated under this agreement.

 

In addition, the Company had previously agreed to indemnify KKR for any claims resulting from its services to the Company and its affiliates. The indemnification was terminated as a result of the Apollo Transaction.

 

The Company has not entered into any significant agreement subsequent to January 1, 2003 that would require it, as a guarantor, to recognize a liability for the fair value of obligations it has undertaken in issuing the guarantee.

 

Warranties

 

The Company does not make express warranties on its products, other than that they comply with the Company’s specifications; therefore, the Company does not record a warranty liability. Adjustments for product quality claims are not material and are charged against sales revenues.

 

8. Commitments and Contingencies

 

Environmental Matters

 

Because the Company’s operations involve the use, handling, processing, storage, transportation and disposal of hazardous materials, the Company is subject to extensive environmental regulation at the Federal and state level and is exposed to the risk of claims for environmental remediation or restoration. In addition, violations of environmental laws or permits may result in restrictions being imposed on operating activities, substantial fines, penalties, damages or other costs, any of which could have a material adverse effect on the Company’s business, financial condition, results of operations or cash flows.

 

Accruals for environmental matters are recorded following the guidelines of Statement of Position 96-1, “Environmental Remediation Liabilities,” when it is probable that a liability has been incurred and the amount of the liability can be estimated. Environmental accruals are reviewed on an interim basis and as events and developments warrant. Based on management’s estimates, which are determined through historical experience and consultation with outside experts, the Company has recorded liabilities, relating to 57 locations, of approximately $37,200 and $38,200 at March 31, 2005 and December 31, 2004, respectively, for all probable environmental remediation, indemnification and restoration liabilities. These amounts include estimates of unasserted claims the Company believes are probable of loss and reasonably

 

12


Table of Contents

estimable. Based on the factors discussed below and currently available information and analysis, the Company believes that it is reasonably possible that costs associated with such sites may fall within a range of $24,900 to $77,400, in the aggregate, at March 31, 2005. This estimate of the range of reasonably possible costs is less certain than the estimates upon which the liabilities are based, and in order to establish the upper end of such range, assumptions less favorable to the Company among the range of reasonably possible outcomes were used. As with any estimate, if facts or circumstances change, the final outcome could differ materially from these estimates. The Company has not taken into consideration insurance coverage or any anticipated recoveries from other third parties in determining the liability or range of possible outcomes. The Company’s current insurance coverage provides very limited, if any, coverage for environmental matters.

 

Following is a more detailed discussion of the Company’s environmental liabilities and related assumptions:

 

BCP Geismar Site – The Company formerly owned a basic chemicals and polyvinyl chloride business which was taken public as Borden Chemicals and Plastics Operating Limited Partnership (“BCPOLP”) in 1987. The Company retained a 1% interest and the general partner interest, which were held by its subsidiary, BCPM. The Company also retained the liability for certain environmental matters after BCPOLP’s formation. Under a Settlement Agreement approved by the United States Bankruptcy Court for the District of Delaware among the Company, BCPOLP, BCPM, the United States Environmental Protection Agency (“EPA”) and the Louisiana Department of Environmental Quality, the Company agreed to perform certain of BCPOLP’s obligations with respect to environmental conditions at BCPOLP’s Geismar, Louisiana site. These obligations are related to soil and groundwater contamination at the Geismar site. The Company bears the sole responsibility for these obligations, as there are no other potentially responsible parties (“PRPs”) or third parties from which the Company can seek reimbursement, and no additional insurance recoveries are expected.

 

A groundwater pump and treat system for the removal of contaminants is operational, and preliminary natural attenuation studies are proceeding. The Company has performed extensive soil and groundwater testing. Regulatory agencies are reviewing the current findings and remediation efforts. If closure procedures and remediation systems prove inadequate, or if additional contamination is discovered, this could result in the costs approaching the higher end of the range of possible outcomes discussed below.

 

The Company has recorded a liability of approximately $20,600 and $21,100 at March 31, 2005 and December 31, 2004, respectively, related to the BCP Geismar site. Based on currently available information and analysis, the Company believes that it is reasonably possible that costs associated with this site may fall within a range of $13,900 to $32,100, depending upon the factors discussed above. Due to the long-term nature of the project, the reliability of timing and the ability to estimate remediation payments, this liability was recorded at its net present value, assuming a 3% discount rate and a time period of thirty years and the range of possible outcomes is discounted similarly. The undiscounted liability is approximately $31,500 over thirty years.

 

Following are expected payments for each of the next five years, and a reconciliation of the expected aggregate payments to the liability reflected at March 31, 2005:

 

2005

   $ 2,000  

2006

     1,600  

2007

     1,600  

2008

     1,500  

2009

     700  

Remaining aggregate payments

     24,100  
    


Total undiscounted liability

     31,500  

Less: discount to net present value

     (10,900 )
    


Liability per Consolidated Balance Sheet

   $ 20,600  
    


 

 

Superfund Sites / Offsite Landfills - The Company is currently involved in environmental remediation activities at 28 sites in which it has been notified that it is, or may be, a PRP under the United States Comprehensive Environmental Response, Compensation and Liability Act (“CERCLA”) or similar state “superfund” laws. The Company has recorded liabilities of approximately $8,100 and $7,900 at March 31, 2005 and December 31, 2004, respectively, related to these sites. The Company anticipates approximately 60% of this liability will be paid within the next five years, with the remaining payments occurring over the next twenty-five years. The Company

 

13


Table of Contents

generally does not bear a significant level of responsibility for these sites, and therefore, has little control over the costs and timing of cash flows. At 16 of the 28 sites, the Company’s share is less than 1%. At the remaining 12 sites, the Company has a share of up to 8.8% of the total liability which accounts for $6,900 and $6,700 of the total amount reserved for superfund / offsite landfill sites at March 31, 2005 and December 31, 2004, respectively. Based on currently available information and analysis, the Company believes that it is reasonably possible that costs associated with all superfund sites may be as low as $5,300 or as high as $17,800, in the aggregate. In estimating both its current reserves for environmental remediation at these sites and the possible range of additional costs, the Company has not assumed that it will bear the entire cost of remediation of every site to the exclusion of other known PRPs who may be jointly and severally liable. The Company has limited information to assess the viability of other PRPs and their probable contribution on a per site basis. The range of possible outcomes also takes into account the maturity of each project, which results in a more narrow range as the project progresses. The Company’s ultimate liability will depend on many factors including its volumetric share of waste, the financial viability of other PRPs, the remediation methods and technology used, the amount of time necessary to accomplish remediation, and the availability of insurance coverage. The Company’s insurance provides very limited, if any, coverage for these environmental matters.

 

Sites Under Current Ownership - The Company is conducting environmental remediation at 5 locations currently owned by the Company, of which 2 sites are no longer operating. There are no other parties responsible for remediation at these sites. Much of the remediation is being performed by the Company on a voluntary basis; therefore, the Company has greater control over the costs to be incurred and the timing of cash flows. The Company has accrued approximately $4,000 and $5,400 at March 31, 2005 and December 31, 2004, respectively, for remediation and restoration liabilities at these locations. The Company anticipates approximately $3,700 of these liabilities will be paid within the next three years, with the remaining amounts being paid over the next ten years. Approximately $3,000 of these reserves is included in the Company’s business realignment reserve, as the environmental clean up is being handled in conjunction with planned closure of the location (see Note 4). Based on currently available information and analysis, the Company believes that it is reasonably possible that costs associated with such sites may fall within a range of $2,600 to $11,600, in the aggregate. The factors influencing the ultimate outcome include the methods of remediation to be elected, the conclusions and assessment of site studies remaining to be completed and the time period required to complete the work.

 

Other Sites - The Company is conducting environmental remediation at 10 locations formerly owned by the Company. The Company has accrued approximately $3,200 and $2,500 at March 31, 2005 and December 31, 2004, respectively, for remediation and restoration liabilities at these locations. The Company anticipates cash outflows of approximately $2,000 within the next three years, with the remainder occurring over the next ten years. Based on currently available information and analysis, the Company believes that it is reasonably possible that costs associated with such sites may fall within a range of $2,400 to $13,800, in the aggregate. The primary drivers in determining the final costs to the Company on these matters are the method of remediation selected and the level of participation of third parties.

 

In addition, the Company is responsible for 12 sites that require monitoring where no additional remediation is expected and has also established accruals for other related costs, such as fines and penalties. The Company has accrued approximately $1,300 at March 31, 2005 and December 31, 2004, related to these sites. Payment of these liabilities is anticipated to occur over the next ten years. Based on currently available information and analysis, the Company believes that it is reasonably possible that costs associated with such sites may fall within a range of $700 and $2,100, in the aggregate. The ultimate cost to the Company will be influenced by any variations in projected monitoring periods or by findings that are better or worse than anticipated findings.

 

The Company formerly operated the Smith Douglass fertilizer business which included a phosphate processing operation in Manatee County, Florida and an animal food processing operation in Hillsborough County, Florida. Both operations were sold in 1980. The EPA has sent the Company and another former owner of the Manatee County facility a request for $112 relating to oversight costs incurred when the site was abandoned by its current owner. The Company is disputing the charge. The Company is aware that state and Federal environmental agencies have taken measures to prevent the off-site release of water from rainfall that accumulated in the drainage ditches and lagoons surrounding the gypsum piles located on this site. The Company is aware that the current owner of the Hillsborough County site ceased operations in March of 2004 and is working with governmental agencies to effect closure of that site. At this time, the Company has received an information

 

14


Table of Contents

request from the EPA, but has not received any demands from any governmental agencies or others regarding the closure and environmental cleanup at this site, which the Company believes is the responsibility of the current owner. While it is reasonably possible some costs could be incurred related to these sites, the Company has inadequate information to enable it to estimate a potential range of liability, if any. As of March 31, 2005, the Company had a reserve of $63 relating to these matters.

 

Non-Environmental Legal Matters

 

Following is a discussion of non-environmental legal proceedings that are not in the ordinary course of business:

 

Imperial Home Décor Group - In 1998, pursuant to a merger and recapitalization transaction sponsored by The Blackstone Group (“Blackstone”) and financing arranged by The Chase Manhattan Bank (“Chase”), Borden Decorative Products Holdings, Inc. (“BDPH”), a wholly owned subsidiary of the Company, was acquired by Blackstone and subsequently merged with Imperial Wallcoverings to create Imperial Home Décor Group (“IHDG”). Blackstone provided $84,500 in equity, a syndicate of banks funded $198,000 of senior secured financing and $125,000 of senior subordinated notes were privately placed. The Company received approximately $309,000 in cash and 11% of IHDG common stock for its interest in BDPH at the closing of the merger. On January 5, 2000, IHDG filed for reorganization under Chapter 11 of the U. S. Bankruptcy Code. The IHDG Litigation Trust (the “Trust”) was created pursuant to the plan of reorganization in the IHDG bankruptcy to pursue preference and other avoidance claims on behalf of the unsecured creditors of IHDG. In November 2001, the Trust filed a lawsuit against the Company and certain of its affiliates in U.S. Bankruptcy Court in Delaware seeking to have the IHDG recapitalization transaction voided as a fraudulent conveyance and asking for a judgment to be entered against the Company for $314,400 plus interest, costs and attorney fees. An effort to resolve this matter through non-binding mediation was unsuccessful in resolving the case and the parties are preparing for trial.

 

The Company has an accrual of $2,300 for legal defense costs related to this matter. The Company has not recorded a liability for any potential losses because a loss is not considered probable based on current information. The Company believes it has strong defenses to the Trust’s allegations and intends to defend the case vigorously. While it is reasonably possible the resolution of this matter may result in a loss due to the many variables involved, the Company is not able to estimate the range of possible outcomes at this time.

 

Brazil Tax Claim - In 1992, the State of Sao Paulo Administrative Tax Bureau issued an assessment against the Company’s primary Brazilian subsidiary claiming that excise taxes were owed on certain intercompany loans made for centralized cash management purposes, characterized by the Tax Bureau as intercompany sales. Since that time, management and the Tax Bureau have held discussions, and the subsidiary has filed an administrative appeal seeking cancellation of the assessment. The Administrative Court upheld the assessment in December 2001. In 2002, the subsidiary filed a second appeal with the highest-level Administrative Court, again seeking cancellation of the assessment. Argument was made to the court in September 2004 and the Company is awaiting its ruling.

 

At March 31, 2005, the amount of the assessment, including tax, penalties, monetary correction and interest, is 63.3 million Brazilian Reais, or approximately $23,700. The Company believes it has a strong defense against the assessment and will pursue the appeal vigorously, including appealing to the judicial level; however, there is no assurance that the assessment will not be upheld. At this time the Company does not believe a loss is probable; therefore, only related legal fees have been accrued. Reasonably possible losses to the Company resulting from the resolution of this matter range from zero to $23,700.

 

HAI Grand Jury Investigation –HAI received a grand jury subpoena dated November 5, 2003 from the U.S. Department of Justice Antitrust Division relating to a foundry resins Grand Jury investigation. HAI has provided documentation in response to the subpoena. As is frequently the case when such investigations are in progress, various antitrust lawsuits have been brought against the Company alleging that the Company and HAI, along with various other entities, engaged in a price fixing conspiracy. At this time the Company does not believe a loss is probable; therefore, only related legal fees have been accrued. The Company does not have sufficient information to determine a range of possible outcomes for this matter at this time.

 

15


Table of Contents

CTA Acoustics – From the third quarter 2003 to the first quarter 2004, six lawsuits were filed against the Company in the 27th Judicial District, Laurel County Circuit Court, in Kentucky, arising from an explosion at a customer’s plant where seven plant workers were killed and over 40 other workers were injured. The lawsuits primarily seek recovery for wrongful death, emotional and personal injury, loss of consortium, property damage and indemnity. The Company expects that a number of these suits will be consolidated. The litigation also includes claims by its customer against its insurer and the Company. The Company is pursuing a claim for indemnity against its customer, based on language in its contract with the customer, and a claim against a third party that performed services for the Company in connection with sales to the customer. The Company previously accrued $5,000, the amount of its insurance deductible, relating to these actions and has insurance coverage to address any payments and legal fees in excess of this amount.

 

Other Legal Matters - The Company has been served in two lawsuits filed in Hillsborough County, Florida Circuit Court which name the Company and several other parties, relating to an animal feed supplement processing site formerly operated by the Company and sold in 1980. The lawsuits are filed on behalf of multiple residents of Hillsborough County living near the site and allege various injuries related to exposure to toxic chemicals. At this time, the Company has inadequate information from which to estimate a potential range of liability, if any.

 

The Company is involved in various product liability, commercial and employment litigation, personal injury, property damage and other legal proceedings which are considered to be in the ordinary course of business. There has been increased publicity about asbestos liabilities faced by manufacturing companies. In large part, as a result of the bankruptcies of many asbestos producers, plaintiff’s attorneys are increasing their focus on peripheral defendants, including the Company, and asserting that even products that contained a small amount of asbestos caused injury. Plaintiffs are also focusing on alleged harm caused by other products we have made or used, including those containing silica and vinyl chloride monomer. The Company does not believe that it has a material exposure relating to these claims and believes it has adequate reserves and insurance to cover currently pending and foreseeable future claims.

 

The Company has reserved approximately $16,700 and $19,800 at March 31, 2005 and December 31, 2004, respectively, relating to all non-environmental legal matters for legal defense and settlement costs that it believes are probable and estimable at this time.

 

Other Commitments and Contingencies

 

The Limited Liability Agreement of HAI provides Delta the right to purchase between 3-5% of additional interest in HAI each year, beginning in 2004. Delta is limited to acquiring a maximum of 25% of additional interest in HAI under this arrangement. Pursuant to this provision, Delta has purchased a 10% interest in HAI from the Company, 5% during the third quarter of 2004 and 5% during the first quarter 2005, reducing the Company’s interest in HAI to 65%. Delta’s purchase price of the interest is based on the enterprise value of HAI determined by applying a contractually agreed upon multiple to EBITDA, as defined in the agreement. See Note 3.

 

The Fentak Pty. Ltd. acquisition agreement includes a contingent purchase consideration provision based on achievement of certain targeted earnings before interest and taxes. Maximum annual payments are AU$600 for the period 2005-2006.

 

16


Table of Contents

9. Pension and Postretirement Expense

 

Following are the components of net pension and postretirement expense recognized by the Company for the periods ended March 31, 2005 and 2004:

 

     Pension

    Postretirement

 
    

Three months ended

March 31,


   

Three months ended

March 31,


 
     2005

    2004

    2005

    2004

 

Service cost

   $ 872     $ 746     $ 34     $ 19  

Interest cost

     3,355       3,480       252       369  

Expected return on plan assets

     (4,036 )     (4,157 )     —         —    

Amortization

                                

Prior service cost

     74       109       (2,795 )     (2,589 )

Recognized net actuarial loss

     1,669       1,608       (144 )     —    
    


 


 


 


     $ 1,934     $ 1,786     $ (2,653 )   $ (2,201 )
    


 


 


 


 

The amortization of prior service cost included in the postretirement benefit relates to the plan amendments made in 2004 and 2003.

 

10. Segment Data

 

The Company consists of three reportable segments: Forest Products, Performance Resins and International. Consolidated results also include Corporate and Other, which is reported separately. The product lines included in the Forest Products segment are formaldehyde and forest product resins. The key business drivers in the Forest Products segment are housing starts, furniture demand, panel production capacity and chemical sector operating conditions. The Performance Resins segment includes oilfield, foundry and specialty resins. In the Performance Resins segment, the key business drivers are housing starts, auto builds, active gas drilling rigs and the general industrial sector. The International segment consists of operations in Europe, Latin America and Asia Pacific. Principal countries of operation are the U.K., Brazil, Australia and Malaysia. Product lines include formaldehyde, forest product and performance resins and consumer products. In the International segment, the key business drivers are export levels, panel production capacity, housing starts, furniture demand and the local political environment. Corporate and Other represents general and administrative expenses and income and expenses related to liabilities retained from businesses sold in previous years.

 

Operating Results by Segment:

 

Following is a comparison of net sales and Segment EBITDA. Segment EBITDA is equal to income (loss) before depreciation and amortization, interest expense, other non-operating expenses or income, income taxes and other adjustments (which include costs included in operating income associated with the Apollo Transaction, business realignment activities, certain costs primarily related to legacy businesses, dispositions and pension settlement charges, if any). Segment EBITDA is presented by reportable segment and for Corporate and Other of the Company for the three months ended March 31, 2005 and 2004. Segment EBITDA information is presented with the Company’s segment disclosures because it is the measure used by the Company’s management in the evaluation of operating results and in determining allocations of capital resources among the business segments. It is also the metric used by the Company to set management and executive incentive compensation.

 

Net Sales              
     2005

   2004

Forest Products

   $ 256,082    $ 194,667

Performance Resins

     123,054    $ 101,964

International

     106,030      88,803
    

  

     $ 485,166    $ 385,434
    

  

 

17


Table of Contents
Segment EBITDA                 
     2005

    2004

 

Forest Products

   $ 28,399     $ 23,721  

Performance Resins

     15,382       11,019  

International

     10,648       9,029  

Corporate and Other

     (10,167 )     (8,922 )
    


 


     $ 44,262     $ 34,847  
    


 


 

The table below reconciles Segment EBITDA to net (loss) income, which management believes to be the most directly comparable GAAP financial measure.

 

Reconciliation of Segment EBITDA to Net (Loss) Income                 
     Three Months ended
March 31,


 
     2005

    2004

 

Segment EBITDA

   $ 44,262     $ 34,847  

Depreciation and amortization

     (12,360 )     (11,943 )

Adjustments to Segment EBITDA (described below)

     67       (2,102 )

Interest expense

     (21,785 )     (11,890 )

Other non-operating expense

     (9,113 )     (61 )

Income tax expense

     (5,333 )     (3,937 )
    


 


Net (loss) income

   $ (4,262 )   $ 4,914  
    


 


 

Adjustments to Segment EBITDA

 

The following items are not included in Segment EBITDA:

 

Three months ended March 31, 2005


  

Plant

Closure(1)


    Severance

    Other

    Total

 

Forest Products

   $ (196 )   $ —       $ —       $ (196 )

Performance Resins

     (215 )     —         1,614 (2)     1,399  

International

     (116 )     —         1,005 (3)     889  

Corporate and Other

     —         (96 )     (1,929 )(4)     (2,025 )
    


 


 


 


     $ (527 )   $ (96 )   $ 690     $ 67  
    


 


 


 



(1) Plant closure costs include fixed asset write-offs, plant employee severance and demolition, environmental and other related costs.
(2) Represents the gain on the sale of an additional 5% interest of HAI to Delta. See Note 3.
(3) Represents a gain on the sale of assets impaired in 2004. See Note 4.
(4) Primarily represents transaction costs associated with the Hexion Combination. See Note 1.

 

Three months ended March 31, 2004


   (1) Plant Closure

    Severance

    (2) Other

    Total

 

Forest Products

   $ (22 )   $ (274 )   $ (39 )   $ (335 )

International

     (748 )     (153 )     —         (901 )

Corporate and Other

     13       (310 )     (569 )     (866 )
    


 


 


 


     $ (757 )   $ (737 )   $ (608 )   $ (2,102 )
    


 


 


 



(1) Plant closure costs include fixed asset write-offs, plant employee severance and demolition, environmental and other related costs.
(2) Primarily represents severance expense, included in general and administrative expense, incurred by the Company for positions to be replaced.

 

18


Table of Contents

11. Guarantor/Non-Guarantor Subsidiary Financial Information

 

In conjunction with the Apollo Transaction, the Company formed two wholly owned finance subsidiaries to borrow $475 million through a private debt offering. The Company and certain of its subsidiaries guarantee this debt. The following information contains the condensed consolidating financial information for the parent, Borden Chemical, Inc., the subsidiary issuers (Borden U.S. Finance Corporation and Borden Nova Scotia, ULC), the subsidiary guarantors (BDS Two, Inc., Borden Chemical Investments, Inc., Borden Chemical Foundry, Inc. and Borden Services Company) and the combined non-guarantor subsidiaries, which includes all of the Company’s foreign subsidiaries and HAI. All of the subsidiary issuers and subsidiary guarantors are owned 100% by the Company. All guarantees are full and unconditional and are joint and several. There are no significant restrictions on the ability of the Company to obtain funds from its domestic subsidiaries by dividend or loan. While the Company’s Australian subsidiary and HAI are restricted in the payment of dividends and intercompany loans due to the terms of their credit facilities, there are no material restrictions on the Company’s ability to obtain cash from the remaining non-guarantor subsidiaries.

 

This information includes allocations of Corporate overhead to the combined non-guarantor subsidiaries based on Net sales. Income tax expense has been provided on the combined non-guarantor subsidiaries based on actual effective tax rates. All other tax expense is reflected in the parent.

 

19


Table of Contents

BORDEN CHEMICAL, INC.

Notes to Condensed Consolidated Financial Statements

(Dollars in thousands)

 

THREE MONTHS ENDED MARCH 31, 2005

CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS

 

     Borden
Chemical,
Inc.


    Subsidiary
Issuers


    Combined
Subsidiary
Guarantors


    Combined
Non-
Guarantor
Subsidiaries


    Eliminations

    Consolidated

 

Net sales

   $ 286,061     $ —       $ —       $ 240,515     $ (41,410 )   $ 485,166  

Cost of goods sold

     240,903       —         —         195,816       (41,410 )     395,309  
    


 


 


 


 


 


Gross margin

     45,158       —         —         44,699       —         89,857  
    


 


 


 


 


 


Distribution expense

     12,182       —         —         9,163       —         21,345  

Marketing expense

     5,922       —         —         6,037       —         11,959  

General & administrative expense

     11,771       —         63       11,911       —         23,745  

Transaction related costs

     791       —         —         709       —         1,500  

Business realignment and impairments (income) expense

     318       —         —         (700 )     —         (382 )

Other operating expense (income)

     1,689       —         (1,666 )     (302 )     —         (279 )
    


 


 


 


 


 


Operating income

     12,485       —         1,603       17,881       —         31,969  
    


 


 


 


 


 


Interest expense

     9,651       10,599       —         1,535       —         21,785  

Intercompany interest expense (income)

     57,648       (11,342 )     (52,948 )     6,642       —         —    

Intercompany royalty expense (income)

     5,779       —         (5,779 )     —         —         —    

Equity in (earnings) losses of subsidiaries, net

     (67,126 )     —         (2,038 )     —         69,164       —    

Other non-operating expense (income)

     9,183       990       —         (1,060 )     —         9,113  
    


 


 


 


 


 


Income (loss) before income tax

     (2,650 )     (247 )     62,368       10,764       (69,164 )     1,071  

Income tax expense

     1,612       —         —         3,721       —         5,333  
    


 


 


 


 


 


Net (loss) income

   $ (4,262 )   $ (247 )   $ 62,368     $ 7,043     $ (69,164 )   $ (4,262 )
    


 


 


 


 


 


 

20


Table of Contents

BORDEN CHEMICAL, INC.

Notes to Condensed Consolidated Financial Statements

(Dollars in thousands)

 

THREE MONTHS ENDED MARCH 31, 2004

CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS

 

     Borden
Chemical,
Inc.


    Subsidiary
Issuers


   Combined
Subsidiary
Guarantors


    Combined
Non-
Guarantor
Subsidiaries


    Eliminations

    Consolidated

Net sales

   $ 226,547     $ —      $ —       $ 189,305     $ (30,418 )   $ 385,434

Cost of goods sold

     186,236       —        —         154,431       (30,418 )     310,249
    


 

  


 


 


 

Gross margin

     40,311       —        —         34,874       —         75,185
    


 

  


 


 


 

Distribution expense

     10,248       —        —         7,080       —         17,328

Marketing expense

     5,563       —        —         5,840       —         11,403

General & administrative expense

     10,769       —        117       11,988       —         22,874

Business realignment expense and impairments

     441       —        —         1,053       —         1,494

Other operating expense (income)

     1,574       —        (25 )     (265 )     —         1,284
    


 

  


 


 


 

Operating income (loss)

     11,716       —        (92 )     9,178       —         20,802
    


 

  


 


 


 

Interest expense

     11,511       —        —         379       —         11,890

Intercompany interest expense (income)

     26,054       —        (26,325 )     271       —         —  

Intercompany royalty expense (income)

     4,688       —        (4,688 )     —         —         —  

Equity in (earnings) losses of subsidiaries, net

     (35,787 )     —        (1,281 )     —         37,068       —  

Other non-operating expense (income)

     617       —        —         (556 )     —         61
    


 

  


 


 


 

Income before income tax

     4,633       —        32,202       9,084       (37,068 )     8,851

Income tax expense (benefit)

     (281 )     —        —         4,218       —         3,937
    


 

  


 


 


 

Net income

   $ 4,914     $ —      $ 32,202     $ 4,866     $ (37,068 )   $ 4,914
    


 

  


 


 


 

 

21


Table of Contents

BORDEN CHEMICAL, INC.

Notes to Condensed Consolidated Financial Statements

(Dollars in thousands)

 

MARCH 31, 2005

CONDENSED CONSOLIDATING BALANCE SHEET

 

     Borden
Chemical,
Inc.


    Subsidiary
Issuers


   Combined
Subsidiary
Guarantors


    Combined
Non-
Guarantor
Subsidiaries


    Eliminations

    Consolidated

 

ASSETS

                                               

Current Assets

                                               

Cash and equivalents

   $ 64,654     $ 46    $ 444     $ 59,164     $ —       $ 124,308  

Accounts receivable

     84,296       —        5,752       127,570       —         217,618  

Intercompany accounts receivable

     23,525       9,656      7,683       6,940       (47,804 )     —    

Inventories:

                                               

Finished & in-process goods

     30,350       —        —         23,658       —         54,008  

Raw materials and supplies

     28,302       —        —         22,939       —         51,241  

Other current assets

     11,865       —        —         4,423       —         16,288  
    


 

  


 


 


 


       242,992       9,702      13,879       244,694       (47,804 )     463,463  
    


 

  


 


 


 


Other Assets

                                               

Investment in subsidiaries

     6,304,528       —        11,604       —         (6,316,132 )     —    

Loans receivable from affiliates

             480,970      6,211,207       40,511       (6,732,688 )     —    

Other assets

     23,214       17,921      —         21,192       —         62,327  
    


 

  


 


 


 


       6,327,742       498,891      6,222,811       61,703       (13,048,820 )     62,327  
    


 

  


 


 


 


Property and Equipment

                                               

Land

     24,347       —        —         8,827       —         33,174  

Buildings

     65,857       —        —         37,636       —         103,493  

Machinery and equipment

     420,271       —        531       314,031       —         734,833  
    


 

  


 


 


 


       510,475       —        531       360,494       —         871,500  

Less accumulated depreciation

     (271,840 )     —        (485 )     (158,411 )     —         (430,736 )
    


 

  


 


 


 


       238,635       —        46       202,083       —         440,764  

Goodwill

     34,491       —        —         15,964       —         50,455  

Other intangible assets

     4,477       —        —         5,420       —         9,897  
    


 

  


 


 


 


Total Assets

   $ 6,848,337     $ 508,593    $ 6,236,736     $ 529,864     $ (13,096,624 )   $ 1,026,906  
    


 

  


 


 


 


LIABILITIES AND SHAREHOLDER’S DEFICIT

                                               

Current Liabilities

                                               

Accounts and drafts payable

   $ 114,633     $ —      $ 5     $ 93,678     $ —       $ 208,316  

Intercompany accounts payable

     11,589       627      100       35,488       (47,804 )     —    

Debt payable within one year

     1,794       —        —         6,387       —         8,181  

Income taxes payable

     31,830       —        —         1,786       —         33,616  

Interest payable

     7,466       8,480      —         10       —         15,956  

Other current liabilities

     63,316       —        5,602       23,508       —         92,426  
    


 

  


 


 


 


       230,628       9,107      5,707       160,857       (47,804 )     358,495  

Other Liabilities

                                               

Long-term debt

     473,582       475,000      —         6,575       —         955,157  

Long-term intercompany loans payable

     6,448,959       —        —         283,729       (6,732,688 )     —    

Non-pension postemployment benefit obligations

     109,329       —        —         1,495       —         110,824  

Other long-term liabilities

     140,750       —        —         16,591       —         157,341  
    


 

  


 


 


 


       7,172,620       475,000      —         308,390       (6,732,688 )     1,223,322  
    


 

  


 


 


 


Shareholder’s (Deficit) Equity

     (554,911 )     24,486      6,231,029       60,617       (6,316,132 )     (554,911 )
    


 

  


 


 


 


Total Liabilities & Shareholder’s (Deficit) Equity

   $ 6,848,337     $ 508,593    $ 6,236,736     $ 529,864     $ (13,096,624 )   $ 1,026,906  
    


 

  


 


 


 


 

22


Table of Contents

BORDEN CHEMICAL, INC.

Notes to Condensed Consolidated Financial Statements

(Dollars in thousands)

 

DECEMBER 31, 2004

CONDENSED CONSOLIDATING BALANCE SHEET

 

     Borden
Chemical,
Inc.


    Subsidiary
Issuers


   Combined
Subsidiary
Guarantors


    Combined
Non-
Guarantor
Subsidiaries


    Eliminations

    Consolidated

 

ASSETS

                                               

Current Assets

                                               

Cash and equivalents

   $ 55,199     $ 2    $ 600     $ 66,310     $ —       $ 122,111  

Accounts receivable

     98,694       —        209       127,332       —         226,235  

Accounts receivable from affiliates

     24,927       15,494      7,684       6,734       (54,839 )     —    

Inventories:

                                    —            

Finished & in-process goods

     33,027       —        —         22,629       —         55,656  

Raw materials and supplies

     29,826       —        —         24,942       —         54,768  

Other current assets

     18,614       —        17       4,360       —         22,991  
    


 

  


 


 


 


       260,287       15,496      8,510       252,307       (54,839 )     481,761  
    


 

  


 


 


 


Other Assets

                                               

Investment in subsidiaries

     6,242,903       —        15,638       —         (6,258,541 )     —    

Loans receivable from affiliates

     —         482,382      6,152,367       40,144       (6,674,893 )     —    

Other assets

     14,685       18,505      —         20,124       —         53,314  
    


 

  


 


 


 


       6,257,588       500,887      6,168,005       60,268       (12,933,434 )     53,314  
    


 

  


 


 


 


Property and Equipment

                                               

Land

     24,074       —        —         8,871       —         32,945  

Buildings

     65,654       —        —         37,850       —         103,504  

Machinery and equipment

     417,776       —        531       314,978       —         733,285  
    


 

  


 


 


 


       507,504       —        531       361,699       —         869,734  

Less accumulated depreciation

     (266,500 )     —        (481 )     (154,747 )     —         (421,728 )
    


 

  


 


 


 


       241,004       —        50       206,952       —         448,006  

Goodwill

     34,623       —        —         16,059       —         50,682  

Other intangible assets

     4,829       —        —         5,522       —         10,351  
    


 

  


 


 


 


Total Assets

   $ 6,798,331     $ 516,383    $ 6,176,565     $ 541,108     $ (12,988,273 )   $ 1,044,114  
    


 

  


 


 


 


LIABILITIES AND SHAREHOLDER’S DEFICIT

                                               

Current Liabilities

                                               

Accounts and drafts payable

   $ 117,978     $ —      $ 23     $ 104,172     $ —       $ 222,173  

Intercompany accounts payable

     10,274       1,727      103       42,735       (54,839 )     —    

Debt payable within one year

     3,588       —        —         8,000       —         11,588  

Income taxes payable

     32,398       —        —         (842 )     —         31,556  

Interest payable

     12,475       13,510      —         37       —         26,022  

Other current liabilities

     53,688       —        7       20,722       —         74,417  
    


 

  


 


 


 


       230,401       15,237      133       174,824       (54,839 )     365,756  

Other Liabilities

                                               

Long-term debt

     473,582       475,000      —         7,234       —         955,816  

Long-term loans payable to affiliates

     6,389,725       —        —         285,168       (6,674,893 )     —    

Non-pension postemployment benefit obligations

     113,026       —        —         1,476       —         114,502  

Other long-term liabilities

     140,422       —        —         16,443       —         156,865  
    


 

  


 


 


 


       7,116,755       475,000      —         310,321       (6,674,893 )     1,227,183  
    


 

  


 


 


 


Shareholder’s (Deficit) Equity

     (548,825 )     26,146      6,176,432       55,963       (6,258,541 )     (548,825 )
    


 

  


 


 


 


Total Liabilities & Shareholder’s (Deficit) Equity

   $ 6,798,331     $ 516,383    $ 6,176,565     $ 541,108     $ (12,988,273 )   $ 1,044,114  
    


 

  


 


 


 


 

23


Table of Contents

BORDEN CHEMICAL, INC.

Notes to Condensed Consolidated Financial Statements

(Dollars in thousands)

 

THREE MONTHS ENDED MARCH 31, 2005

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

 

     Borden
Chemical,
Inc.


    Subsidiary
Issuers


    Combined
Subsidiary
Guanantors


    Combined
Non-
Guarantor
Subsidiaries


    Eliminations

    Consolidated

 

Cash Flows from (used in) Operating Activities

                                                

Net (loss) income

   $ (4,262 )   $ (247 )   $ 62,368     $ 7,043     $ (69,164 )   $ (4,262 )

Adjustments to reconcile net (loss) income to net cash from (used in) operating activities:

                                                

Non-cash affiliated interest (1)

     52,840       —         (52,840 )     —         —         —    

Non-cash allocation of corporate expenses

     (5,271 )     —         —         5,271       —         —    

Equity in earnings of subsidiaries

     (67,126 )     —         (2,038 )     —         69,164       —    

Depreciation and amortization

     7,228       —         5       5,127       —         12,360  

Deferred tax expense (benefit)

     931       —         —         (23 )     —         908  

Unrealized loss on derivative instruments

     9,576       —         —         233       —         9,809  

Business realignment and impairments (income) expense

     318       —         —         (700 )     —         (382 )

Gain on sale of venture interest

     —         —         (1,614 )     —         —         (1,614 )

Other non-cash adjustments

     1,048       —         —         (1,058 )     —         (10 )

Net change in assets & liabilities:

                                     —            

Accounts receivable

     9,055       —         58       (790 )     —         8,323  

Inventories

     4,201       —         —         729       —         4,930  

Accounts and drafts payable

     7,505       (1,100 )     (21 )     (19,910 )     —         (13,526 )

Income taxes

     (546 )     —         —         2,672       —         2,126  

Other assets

     5,514       6,422       (69 )     (5,258 )     —         6,609  

Other liabilities

     (13,856 )     (6,443 )     (5 )     7,205       —         (13,099 )
    


 


 


 


 


 


       7,155       (1,368 )     5,844       541       —         12,172  
    


 


 


 


 


 


Cash Flows (used in) from Investing Activities

                                                

Capital expenditures

     (4,659 )     —         —         (1,822 )     —         (6,481 )

Deferred acquisition costs

     (9,128 )     —         —         —         —         (9,128 )

Proceeds from sale of venture interest

     —         —         2,507       —         —         2,507  
    


 


 


 


 


 


       (13,787 )     —         2,507       (1,822 )     —         (13,102 )
    


 


 


 


 


 


Cash flows (used in) from Financing Activities

                                                

Net short-term debt repayments

     (1,794 )     —         —         (1,613 )     —         (3,407 )

Repayments of long-term debt

     —         —         —         (663 )     —         (663 )

Affiliated loan (repayments) borrowings

     6,394       1,412       (6,000 )     (1,806 )     —         —    

Purchase price adjustment payable to parent

     7,500       —         —         —         —         7,500  

Dividends received (paid)

     3,987       —         (2,507 )     (1,480 )     —         —    
    


 


 


 


 


 


       16,087       1,412       (8,507 )     (5,562 )     —         3,430  
    


 


 


 


 


 


Effect of exchange rates on cash

     —         —         —         (303 )     —         (303 )
    


 


 


 


 


 


Increase (decrease) in cash and equivalents

     9,455       44       (156 )     (7,146 )     —         2,197  

Cash & equivalents beginning of period

     55,199       2       600       66,310       —         122,111  
    


 


 


 


 


 


Cash & equivalents at end of period

   $ 64,654     $ 46     $ 444     $ 59,164     $ —       $ 124,308  
    


 


 


 


 


 



(1) Interest on affiliated debt to certain guarantor subsidiaries is settled by increasing the loan principal.

 

24


Table of Contents

BORDEN CHEMICAL, INC.

Notes to Condensed Consolidated Financial Statements

(Dollars in thousands)

 

THREE MONTHS ENDED MARCH 31, 2004

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

 

     Borden
Chemical,
Inc.


    Subsidiary
Issuers


   Combined
Subsidiary
Guarantors


    Combined
Non-
Guarantor
Subsidiaries


    Eliminations

    Consolidated

 

Cash Flows from (used in) Operating Activities

                                               

Net income

   $ 4,914     $ —      $ 32,202     $ 4,866     $ (37,068 )   $ 4,914  

Adjustments to reconcile net income to net cash from (used in) operating activities:

                                               

Non-cash affiliated interest (1)

     26,235       —        (26,235 )     —         —         —    

Equity in earnings of subsidiaries

     (35,787 )     —        (1,281 )     —         37,068       —    

Non-cash allocation of corporate expenses

     (3,801 )     —        —         3,801       —         —    

Depreciation and amortization

     7,299       —        31       4,613       —         11,943  

Deferred tax expense (benefit)

     (1,427 )     —        —         65       —         (1,362 )

Business realignment expense and impairments

     441       —        —         1,053       —         1,494  

Unrealized gain on derivative instruments

     (145 )     —        —         —         —         (145 )

Other non-cash adjustments

     986       —        —         (5 )     —         981  

Net change in assets and liabilities:

                                    —            

Accounts receivable

     (5,025 )     —        8       1,404       —         (3,613 )

Inventories

     5,131       —        —         (2,893 )     —         2,238  

Accounts and drafts payable

     8,143       —        (13 )     7,856       —         15,986  

Income taxes

     520       —        —         (1,545 )     —         (1,025 )

Other assets

     581       —        43       (8,658 )     —         (8,034 )

Other liabilities

     (15,932 )     —        (13 )     (1,601 )     —         (17,546 )
    


 

  


 


 


 


       (7,867 )     —        4,742       8,956       —         5,831  
    


 

  


 


 


 


Cash Flows from (used in) Investing Activities

                                               

Capital expenditures

     (3,336 )     —        —         (4,135 )     —         (7,471 )

Proceeds from the sale of assets

     —         —        —         8,105       —         8,105  
    


 

  


 


 


 


       (3,336 )     —        —         3,970       —         634  
    


 

  


 


 


 


Cash flows (used in) from Financing Activities

                                               

Net short-term debt repayments

     (1,529 )     —        —         (1,497 )     —         (3,026 )

Borrowings of long-term debt

     —         —        —         3,028       —         3,028  

Affiliated loan (repayments) borrowings

     (2,143 )     —        10,000       (12,817 )     —         (4,960 )

Dividends received (paid)

     14,600       —        (14,600 )     —         —         —    
    


 

  


 


 


 


       10,928       —        (4,600 )     (11,286 )     —         (4,958 )
    


 

  


 


 


 


Effect of exchange rates on cash

     —         —        —         (37 )     —         (37 )
    


 

  


 


 


 


Increase (decrease) in cash and equivalents

     (275 )     —        142       1,603       —         1,470  

Cash and equivalents beginning of period

     1,370       —        151       26,641       —         28,162  
    


 

  


 


 


 


Cash and equivalents at end of period

   $ 1,095     $ —      $ 293     $ 28,244     $ —       $ 29,632  
    


 

  


 


 


 



(1) Interest on affiliated debt to certain guarantor subsidiaries is settled by increasing the loan principal

 

25


Table of Contents

12. Subsequent Events

 

Bakelite Acquisition

 

On April 29, 2005, Borden Chemical Canada, Inc., a subsidiary of the Company, through its wholly owned subsidiary, National Borden Chemical Germany Gmbh, completed its acquisition of Bakelite Aktiengesellschaft (“Bakelite”) pursuant to a share purchase agreement with RUTGERS AG and RUTGERS Bakelite Projekt GmbH (collectively, the “Sellers”) dated October 6, 2004. Based in Iserlohn-Letmathe, Germany, Bakelite is a leading source of phenolic and epoxy thermosetting resins and molding compounds with 13 manufacturing facilities and 1,700 employees in Europe and Asia.

 

In the transaction, the Sellers exchanged all of their respective shares of Bakelite’s stock for cash and debt assumed in an aggregate amount of EUROS 207,000, or approximately $267,000. The transaction was financed via a second-priority senior secured bridge loan facility in the amount of $250,000 and available cash. The bridge financing arrangement has a variable interest rate equal to LIBOR plus an applicable margin and has a final maturity date of July 15, 2014. The acquisition will be accounted for under the purchase method of accounting.

 

Hexion Combination

 

As of April 22, 2005, the Company entered into a merger agreement with Resolution Performance Products, Inc. (“RPP”) and Resolution Specialty Materials, Inc. (“RSM”) (the “Merger”). The Company, RPP and RSM are controlled by Apollo. The Merger is expected to close during the second quarter of 2005. Upon the consummation of the Merger, the Company will change its name to Hexion Specialty Chemicals, Inc. (“Hexion”). Completion of the Merger is subject to customary closing conditions and the Company, RPP and RSM will continue to operate independently until those conditions are satisfied and each of the closings occur. The Merger will be treated, for accounting purposes, as a combination of entities under common control.

 

Hexion Preferred Stock

 

In May 2005, Hexion Escrow Corp., which will be merged with Hexion upon consummation of the Merger, offered 14 million shares of Series A Floating Rate Preferred Stock (the “Preferred Stock”), par value $0.01 per share, and initial liquidation preference of $25 per share. The Preferred Stock will accumulate cumulative preferential dividends from the issue date at an initial rate of LIBOR plus 8.0%, compounded semi-annually. Prior to November 2005, the Company has the option to redeem all or a portion of the Preferred Stock at 100% of the aggregate liquidation value plus accrued and unpaid dividends. The Company expects to use the proceeds from its initial public offering, discussed below, to redeem the Preferred Stock. If the Merger is not consummated by July 31, 2005, the Preferred Stock is subject to special mandatory redemption. The net proceeds from the Preferred Stock issuance are expected to be $336,000, after deducting underwriting expenses and estimated expenses of the offering, and will be used to pay a dividend to the Company’s parent.

 

Registration Statement

 

On April 25, 2005, the Company filed a registration statement, which is not yet effective, with the U.S. Securities and Exchange Commission (the “SEC”) for a proposed initial public offering of its common stock. The Company intends to commence the sale of its common stock to the public, after completion of the Merger and upon approval by the SEC of the registration statement, under the Hexion Specialty Chemicals, Inc. name. The Company and a selling shareholder will sell the shares of common stock. The Company will not receive any of the proceeds from the sale of shares by the selling shareholder. The proceeds from the sale of shares by the Company will be used to redeem the Hexion Preferred Stock discussed above.

 

26


Table of Contents

Item 2: Management’s Discussion and Analysis of Financial Condition and Results of Operations (amounts in thousands)

 

Forward-Looking and Cautionary Statements

 

As management of Borden Chemical, Inc. (which made be referred to as “Borden,” “BCI,” “we,” “us,” “our” or the “Company”) we may, from time to time, make written and oral statements regarding the future performance of the Company, including statements contained in this report and our other reports filed with the Securities and Exchange Commission. Investors should be aware that these statements, which may include words such as “believe,” “expect,” “anticipate,” “estimate” or “intend,” are based on our currently available financial, economic and competitive data and on current business plans. Such risks and uncertainties are primarily in the areas of results of operations by business unit, liquidity, legal and environmental liabilities and industry and economic conditions.

 

Apollo Transaction

 

In the third quarter of 2004, BCI was acquired by an affiliate of Apollo Management, L.P. (“Apollo”). Our immediate parent is BHI Acquisition Corp. (“BHI Acquisition”), which is a wholly owned subsidiary of BHI Investment LLC, an entity controlled by Apollo. The transactions related to the acquisition of the Company by Apollo are referred to collectively as the “Apollo Transaction.”

 

Overview

 

We are a leading global integrated producer of thermoset-based resins and adhesives for the global forest products and industrial markets. In addition, we are the world’s largest producer by volume of formaldehyde, an important and versatile building block chemical used in a variety of applications. We are the largest North American producer by volume of thermoset-based resins used in the production of engineered wood products, including structural wood panels, beams and non-structural panels, furniture, door and window assemblies and wallboards. We are also the largest North American producer by volume of resin-coated proppant systems, which are used in oilfield and natural gas production, and of foundry resins, which are used in the production of cores and molds for metal castings. We have a strong presence in the production of specialty resins used in the industrial, automotive and electronics markets.

 

Our three reporting segments are the following: Forest Products, Performance Resins and International. Our results also include general corporate and administrative expenses disclosed as “Corporate and Other”, presented to provide a complete picture of our results.

 

Forest Products includes the forest product resins and formaldehyde product lines produced in North America. The key business drivers for Forest Products are housing starts, furniture demand, panel production capacity and chemical intermediates sector operating conditions.

 

Performance Resins includes the specialty resins, foundry resins and oilfield product lines produced in North America. Performance Resins’ key business drivers are housing starts, auto builds, active gas drilling rigs and the general industrial sector performance.

 

International includes production operations in Europe, Latin America and Asia Pacific. Principal countries of operation are the U.K., Brazil, Australia and Malaysia. Product lines include formaldehyde, forest product and performance resins and consumer products. The key business drivers for International are export levels, panel production capacity, housing starts, furniture demand and the local political and general economic environments.

 

Corporate and Other represents general and administrative expenses and income and expenses related to liabilities retained from businesses sold in previous years.

 

As of April 22, 2005, we entered into a merger agreement with Resolution Performance Products, Inc., or RPP, and Resolution Specialty Materials, Inc., or RSM. The Company, RPP and RSM are controlled by Apollo. The merger is expected to close during the second quarter of 2005. Upon the consummation of the merger, we will change our name to Hexion Specialty Chemicals, Inc., which we refer to as Hexion. Completion of the merger is subject to customary closing conditions and the Company, RPP and RSM will continue to operate independently until those conditions are satisfied and each of the closings occur. The merger will be treated, for accounting purposes, as a combination of entities under common control. Collectively, we refer to this merger as the Hexion Combination.

 

27


Table of Contents

On April 25, 2005, the Company filed a registration statement, which is not yet effective, with the U.S. Securities and Exchange Commission (“SEC”), for a proposed initial public offering of its common stock. The Company intends to commence the sale of its common stock to the public, after completion of the merger and upon approval by the SEC of the registration statement, under the Hexion Specialty Chemicals, Inc. name.

 

On April 29, 2005, through our wholly owned subsidiary, National Borden Chemical Germany Gmbh, we completed our acquisition of Bakelite Aktiengesellschaft, or Bakelite, pursuant to our share purchase agreement with RUTGERS AG and RUTGERS Bakelite Projekt GmbH dated October 6, 2004. Based in Iserlohn-Letmathe, Germany, Bakelite is a leading source of phenolic and epoxy thermosetting resins and molding compounds with 13 manufacturing facilities and 1,700 employees in Europe and Asia.

 

Overview of Results

 

Our net sales increased $99,732, or 25.9%, in the first quarter of 2005 versus the first quarter of 2004. Net sales benefited from strong pricing and improved product mix. Our strong pricing is due to the pass through of raw material cost increases in all three reporting segments, and we experienced improved product mix primarily in our nonwoven resins and oilfield products. Improved volumes, primarily in formaldehyde, forest products and foundry resins, oilfield products and Europe, also contributed to the increase. Favorable currency translation, in all countries in which we operate, also positively impacted net sales.

 

We reported a net loss of $4,262 for the first quarter of 2005 versus net income of $4,914 for the first quarter of 2004. The $9,176 reduction in net income was primarily due to an increase in interest expense of $9,895, which relates to our issuance of the $475 million of Second Priority Notes in August of 2004 as part of the Apollo Transaction, an increase in other non-operating expense of $8,907, primarily relating to a loss on the mark to market of a deal contingent forward related to the Bakelite Acquisition (see Note 6 to the Condensed Consolidated Financial Statements) and an increase in income tax expense of $1,396. Offsetting these increased expenses was an increase in operating income of $12,667. The increase in operating income was primarily driven by increased volumes, higher average selling prices and lower business realignment expenses.

 

Critical Accounting Policies

 

For a discussion of our critical accounting policies, refer to Management’s Discussion and Analysis of Financial Condition and Results of Operations in Item 7 on page 17 and in Note 2 to the Consolidated Financial Statements on page 43 of the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 28, 2005. Our critical accounting policies did not change during the first quarter of 2005.

 

Results of Operations by Segment:

 

Following is a comparison of net sales and Segment EBITDA. Segment EBITDA is equal to income (loss) before depreciation and amortization, interest expense, other non-operating expenses or income, income taxes and other adjustments (which include costs included in operating income associated with the Apollo Transaction, business realignment activities, certain costs primarily related to legacy businesses, dispositions and pension settlement charges, if any). Segment EBITDA is presented by reportable segment and for Corporate and Other of the Company for the three months ended March 31, 2005 and 2004. Segment EBITDA information is presented with the Company’s segment disclosures because it is the measure used by the Company’s management in the evaluation of operating results and in determining allocations of capital resources among the business segments. It is also the metric used by the Company to set management and executive incentive compensation.

 

28


Table of Contents
Net Sales              
     2005

   2004

Forest Products

   $ 256,082    $ 194,667

Performance Resins

     123,054      101,964

International

     106,030      88,803
    

  

     $ 485,166    $ 385,434
    

  

 

Segment EBITDA                 
     2005

    2004

 

Forest Products

   $ 28,399     $ 23,721  

Performance Resins

     15,382       11,019  

International

     10,648       9,029  

Corporate and Other

     (10,167 )     (8,922 )
    


 


     $ 44,262     $ 34,847  
    


 


 

Reconciliation of Segment EBITDA to Net (Loss) Income                 
     Three Months ended
March 31,


 
     2005

    2004

 

Segment EBITDA

   $ 44,262     $ 34,847  

Depreciation and amortization

     (12,360 )     (11,943 )

Adjustments to Segment EBITDA (see page 30)

     67       (2,102 )

Interest expense

     (21,785 )     (11,890 )

Other non-operating expense

     (9,113 )     (61 )

Income tax expense

     (5,333 )     (3,937 )
    


 


Net (loss) income

   $ (4,262 )   $ 4,914  
    


 


 

THREE MONTHS ENDED MARCH 31, 2005 VERSUS THREE MONTHS ENDED MARCH 31, 2004

 

Net Sales Variance


   2005 As a Percentage Increase from 2004

 
   Volume

    Price/Mix

    Translation

    Total

 

Forest Products

   4.4 %   24.1 %   3.0 %   31.5 %

Performance Resins

   5.9 %   14.7 %   0.1 %   20.7 %

International

   2.5 %   11.0 %   5.9 %   19.4 %

 

Forest Products

 

Forest Products’ first quarter net sales of $256,082 increased $61,415, or 31.5%, compared to 2004. Favorable pricing and mix and improved volumes primarily drove the increase in sales. Strong pricing for our phenolic-based, or PF, resins and our urea-based, or UF, resins was primarily due to the pass through of raw material price increases. We experienced improved volumes primarily for our formaldehyde, PF resins and UF resins. The improved formaldehyde volumes were primarily due to broad-based demand in the general chemical sector, while our improved PF and UF resins volumes related to the continued strong housing market. Sales also benefited from favorable currency translation as the Canadian dollar strengthened versus the U.S. dollar.

 

Forest Products Segment EBITDA for the first quarter of 2005 of $28,399 was an increase of $4,678, or 19.7%, over prior year. The improvement in Segment EBITDA was primarily due to improved margins despite continuing high methanol and phenol prices. Our margin improvement is attributed to purchasing productivity and our ability to pass along raw material price increases. Higher volumes and favorable currency translation also contributed to the improvement.

 

29


Table of Contents

Performance Resins

 

Performance Resins’ first quarter net sales of $123,054 were an increase of $21,090, or 20.7%, over the comparable period of the prior year. Increased selling prices and improved volumes were the drivers of the increase. Selling prices increased for our industrial and foundry resins, and we experienced favorable product mix for our nonwoven resins and oilfield products. Improved volumes for our foundry resins and oilfield products were partially offset by reduced volumes for our electronics products. The increase in foundry resins volumes was due to strong demand in the non-automotive casting segments. Strong drilling activity in East Texas, the Rockies and the Mid-Continent region drove the volume increase in oilfield products. The decline in electronics volumes was primarily due to the timing of and change in customer demand.

 

First quarter Segment EBITDA for Performance Resins of $15,382 increased $4,363, or 39.6%, compared to the comparable period of 2004. Volume increases primarily in foundry resins and oilfield products were a main driver of the improvement in Segment EBITDA. Also contributing to the increase was favorable product mix in our industrial resins and reduced processing costs. Offsetting these improvements was increased freight costs across most of our products due to a shift to more prepaid freight deliveries.

 

International

 

First quarter 2005 International sales of $106,030 were an increase of $17,227, or 19.4%, over the first quarter of 2004. Strong pricing, favorable currency translation and improved volumes all contributed to the increase in sales. Strong pricing across all international regions was due to the pass through of higher raw material costs. We experienced favorable currency translation across all international regions as well. Improved European volumes, primarily in Industrial Resins due to the addition of new customers, were partially offset by reduced volumes in Latin America, primarily related to decreased demand for forest product resins in the region. The decrease in demand is due to reduced plywood exports to Europe and the U.S. as a result of market conditions and a less competitive exchange rate.

 

International Segment EBITDA of $10,648 increased $1,619, or 17.9%, in first quarter 2005 compared to the same period of 2004. Reduced processing costs, improved European volumes and favorable currency translation across all international regions drove the improvement in Segment EBITDA. These improvements were partially offset by reduced margins due to competitive pricing pressures in Europe and Asia Pacific and increased freight costs in Europe and Latin America.

 

Corporate and Other

 

Our first quarter 2005 Corporate and Other expenses increased $1,245 compared to our first quarter 2004 expenses. The increase is primarily due to adjustments made to our legal, environmental and general insurance reserves.

 

Adjustments to Segment EBITDA

 

We rely primarily on Segment EBITDA in the evaluation of operating results and the allocation of capital resources. The following tables detail items not included in Segment EBITDA for purposes of this evaluation of our operating segments. We monitor these activities separately from our operating results. These (expense) income items primarily relate to our realignment programs and asset impairments:

 

Three months ended March 31, 2005


   Plant
Closure


    Severance

    Other

    Total

 

Forest Products

   $ (196 )   $ —       $ —       $ (196 )

Performance Resins

     (215 )     —         1,614       1,399  

International

     (116 )     —         1,005       889  

Corporate and Other

     —         (96 )     (1,929 )     (2,025 )
    


 


 


 


     $ (527 )   $ (96 )   $ 690     $ 67  
    


 


 


 


 

Plant closure costs in the first quarter of 2005 of $527 related to costs associated with a plant closing due to changes in the Company’s manufacturing footprint of $216, the transition of manufacturing from the Company’s North Bay, Ontario plant to another facility of $152, environmental remediation of $71 for closed plants in Brazil and other plant closure costs of $88.

 

30


Table of Contents

We recorded severance costs of $96 related primarily to the 2003 realignment program.

 

Other income of $690, not included in first quarter 2004 Adjusted EBITDA, primarily represents the gain recognized on the sale of an additional 5% interest in HA International, our venture interest that we call HAI, and a gain on the sale of assets impaired in 2004. See Notes 3 and 4 to the Condensed Consolidated Financial Statements. These amounts were partially offset by transaction costs associated with the Hexion Combination. See Note 1 to the Condensed Consolidated Financial Statements.

 

Three months ended March 31, 2004


   Plant
Closure


    Severance

    Other

    Total

 

Forest Products

   $ (22 )   $ (274 )   $ (39 )   $ (335 )

International

     (748 )     (153 )     —         (901 )

Corporate and Other

     13       (310 )     (569 )     (866 )
    


 


 


 


     $ (757 )   $ (737 )   $ (608 )   $ (2,102 )
    


 


 


 


 

Plant closure costs in the first quarter of 2004 of $757 related to the conversion of our French manufacturing facility into a distribution center and the transition of the related production to the U.K. ($244), environmental remediation at closed plants in Brazil ($238) and other plant closure costs at various sites ($275).

 

We recorded severance costs of $737 related primarily to the 2003 realignment program.

 

Other expenses of $608 not included in first quarter 2004 Adjusted EBITDA primarily represent severance expense, included in general and administrative expense, for positions to be replaced as part of the 2003 realignment program.

 

Non-operating Expenses and Income Taxes

 

Following is a comparison of our non-operating expenses for the three months ended March 31, 2005 and 2004:

 

     Three months ended
March 31,


     2005

   2004

Interest expense

   $ 21,785    $ 11,890

Other non-operating expense

     9,113      61
    

  

     $ 30,898    $ 11,951
    

  

 

Our total non-operating expenses increased $18,947 in the first quarter of 2005 as compared to the first quarter of 2004. Interest expense increased $9,895 over 2004 due to higher average debt balances resulting from our issuance of the $450 million of Second Priority Notes in August of 2004 as part of the Apollo Transaction. Included in other non-operating expense in 2005 was a $10,432 unrealized loss on the mark to market of a deal contingent forward held by us relating to the pending Bakelite acquisition. See Note 6 to the Condensed Consolidated Financial Statements.

 

Following is a comparison of income tax expense related to continuing operations for the three months ended March 31, 2005 and 2004:

 

    

Three months ended

March 31,


 
     2005

   2004

 

Income tax expense

   $ 5,333    $ 3,937  

Effective tax rate

     N/M      44 %

 

The 2005 income tax expense primarily reflects income taxes on earnings in international jurisdictions, as well as withholding taxes related to the unremitted earnings of foreign subsidiaries.

 

The 2004 effective tax rate reflects the effect of certain foreign losses that we cannot utilize to offset current or future taxable income. Consequently, no tax benefit has been recorded to recognize a current or future benefit of those foreign losses. Additionally, the effective rate reflects higher effective tax rates in certain international jurisdictions.

 

31


Table of Contents

Cash Flows:

 

Cash provided by (used in):

 

     Three months ended
March 31,


 
     2005

    2004

 

Operating activities

   $ 12,172     $ 5,831  

Investing activities

     (13,102 )     634  

Financing activities

     3,430       (4,958 )

Effect of exchange rates on cash flow

     (303 )     (37 )
    


 


Net change in cash and cash equivalents

   $ 2,197     $ 1,470  
    


 


 

Operating Activities

 

Our first quarter 2005 operating activities provided cash of $12,172. Cash generated from earnings after adjusting for non-cash expenses of approximately $16,800 and collections of miscellaneous receivables primarily related to rebates of approximately $25,000 were the primary sources of cash from operating activities. This generation of cash was substantially offset by net trading capital outflows of approximately $16,300 and interest payments of approximately $31,497.

 

Our first quarter 2004 operating activities provided cash of $5,831. Cash generated from earnings after adjusting for non-cash expenses of approximately $17,800 and collections of receivables primarily related to rebates of approximately $8,900 were the primary sources of cash from operating activities. This generation of cash was substantially offset by net interest and tax payments of about $22,400 and net trading capital outflows of approximately $2,600.

 

Investing Activities

 

Our investing activities used cash of $13,102 in the first quarter of 2005. We used $6,481 for capital expenditures, primarily for plant expansions and improvements. In addition, we used $9,128 for deferred acquisition costs associated with the Bakelite acquisition. See Note 1 to the Condensed Consolidated Financial Statements. We received proceeds of $2,507 on our sale of an additional 5% interest in HAI. See Note 3 to the Condensed Consolidated Financial Statements.

 

Our investing activities in the first quarter of 2004 provided cash of $634. We received proceeds of $8,105, primarily from collection on a receivable from the 2003 sale of land associated with a closed plant in the U.K. We used $7,471 for capital expenditures, primarily for plant expansions and improvements.

 

Financing Activities

 

Our financing activities provided cash of $3,430 in the first quarter of 2005. The receipt of a $7,500 purchase price adjustment related to the Apollo Transaction was partially offset by repayments on our short and long-term debt.

 

Our financing activities used cash of $4,958 in the first quarter of 2004. We used this cash primarily to make repayments on our affiliated borrowings.

 

Liquidity and Capital Resources

 

Our primary source of liquidity is cash flow generated from operations. We also have availability under our asset-based revolving line of credit in our senior secured credit facility, which we refer to as our Credit Facility, subject to certain conditions. Our primary liquidity requirements are for debt service, working capital requirements, contractual obligations and capital expenditures.

 

We are a highly leveraged company. Our liquidity requirements are significant, primarily due to our debt service requirements. At March 31, 2005, we had $963,338 principal amount of outstanding indebtedness, of which $150,000 constituted floating rate notes and $813,338 constituted fixed rate indebtedness. We had no amounts borrowed under our Credit Facility at March 31, 2005.

 

32


Table of Contents

We entered into a three-year asset based revolving Credit Facility in the third quarter of 2002, under which we can borrow in aggregate up to $175,000. We amended this Credit Facility, which we refer to as our Amended Credit Facility, on August 12, 2004 as part of the Apollo Transaction. The Amended Credit Facility provides for loans and letters of credit in a total principal amount of up to $175,000 and expires in 2009. The Amended Credit Facility includes a $57,000 revolving credit subfacility for our Canadian subsidiary, a $30,000 revolving credit subfacility for our U.K. subsidiary and a letter of credit subfacility of at least $100,000.

 

Our Amended Credit Facility is secured with inventory and accounts receivable in the U.S., Canada and the U.K., a portion of property and equipment in Canada and the U.K. and the stock of certain subsidiaries. The maximum borrowing allowable under our Amended Credit Facility is calculated monthly (quarterly, if availability is greater than $100,000) and is based upon specific percentages of eligible accounts receivable, inventory, fixed assets and cash. This Amended Credit Facility contains restrictions on dividends, capital expenditures ($75,000 in 2005) and payment of management fees ($3,000 per year or 2% of EBITDA, as defined in the agreement). It also includes a minimum trailing twelve-month fixed charge coverage ratio of 1.1 to 1.0, if aggregate availability is less than $50,000. The trailing twelve-month fixed charge coverage ratio requirement does not apply when aggregate availability exceeds $50,000. At March 31, 2005, our maximum borrowing allowable under the Amended Credit Facility was approximately $175,000 of which about $125,500, after outstanding LOCs and other draws, was unused and available. As a result, we have no fixed charge coverage ratio requirements at March 31, 2005.

 

HAI entered into a three-year asset backed revolving credit facility on January 28, 2004, which provides for a maximum borrowing of $15,000, as amended on October 29, 2004 (the “HAI Facility”). Maximum borrowing allowable under the HAI Facility is based upon specific percentages of eligible accounts receivable and inventory and is secured with inventory, accounts receivable and property and equipment of HAI. The HAI Facility contains restrictions relative to HAI on dividends, affiliate transactions, minimum availability ($2,000), additional debt and capital expenditures ($2,000 in 2005). In addition, HAI is required to maintain a minimum trailing twelve-month debt coverage ratio of 1.5 to 1.0 and a monthly debt to tangible capital ratio of less than 2.5 to 1.0. At March 31, 2005, borrowing allowable under the HAI Facility was approximately $14,500, of which approximately $12,500 was unused and available, after the minimum availability requirement.

 

Our Australian subsidiary entered into a five-year secured credit facility in the fourth quarter of 2003 (the “Australian Facility”), which provides for a maximum borrowing of AUD$19,900, or approximately $15,400. The Australian Facility is secured by liens against substantially all of the assets of the Australian business including the stock of Australian subsidiaries. In addition, the stock of Australia is pledged as collateral for borrowings under the Australian Facility. This facility includes a fixed rate component used for the acquisition, as well as a revolver and LOC facility. This facility restricts the Australian subsidiaries on the payment of dividends, the sale of assets and additional borrowings by the Australian businesses outside of this facility. This facility also contains financial covenants applying to the Australian subsidiaries including current ratio, interest coverage, debt service coverage and leverage. At March 31, 2005, the maximum borrowing allowable under the Australian Facility was AUD$16,900 (approximately $13,100), of which about AUD$2,900 (approximately $2,200), after outstanding LOCs and other draws, was unused and available.

 

As discussed in Note 12 to the Condensed Consolidated Financial Statements, on April 29, 2005, Borden Chemical Canada, Inc., a subsidiary of the Company, through its wholly owned subsidiary, National Borden Chemical Germany Gmbh, completed its acquisition of Bakelite Aktiengesellschaft (“Bakelite”) pursuant to a share purchase agreement with RUTGERS AG and RUTGERS Bakelite Projekt GmbH (collectively, the “Sellers”) dated October 6, 2004. In the transaction, the Sellers exchanged all of their respective shares of Bakelite’s stock for cash in an aggregate amount of EUROS 207,000, or approximately $267,000. The transaction was financed via a second-priority senior secured bridge loan facility in the amount of $250,000 and available cash. The bridge financing arrangement has a variable interest rate equal to LIBOR plus an applicable margin and has a final maturity date of July 15, 2014.

 

Previous buybacks of our senior unsecured notes allow us to fulfill our sinking fund requirements through 2013 for our 8.375% debentures. In the future, we, or our affiliates, including entities controlled by Apollo, may purchase our senior unsecured notes in the open market or by other means, depending on market conditions.

 

We expect to have adequate liquidity to fund working capital requirements, contractual obligations and capital expenditures over the remainder of the five-year term of our Amended Credit Facility with cash received from operations, amounts available under the Amended Credit Facility and amounts available under our subsidiaries’ separate credit facilities.

 

33


Table of Contents

In May 2005, in connection with the Hexion Combination, Hexion Escrow Corp., which will be merged with the Company upon consummation of the Hexion Combination, offered 14 million shares of Series A Floating Rate Preferred Stock, which we refer to as the Preferred Stock, par value $0.01 per share, and initial liquidation preference of $25 per share. The Preferred Stock will accumulate cumulative preferential dividends from the issue date at an initial rate of LIBOR plus 8.0%, compounded semi-annually. Prior to November 2005, the Company has the option to redeem all or a portion of the Preferred Stock at 100% of the aggregate liquidation value plus accrued and unpaid dividends. The Company expects to use the proceeds from its initial public offering, discussed in the Overview section above, to redeem the Preferred Stock. If the Hexion Combination is not consummated by July 31, 2005, the Preferred Stock is subject to special mandatory redemption. The net proceeds from the Preferred Stock issuance are expected to be $336,000, after deducting underwriting expenses and estimated expenses of the offering, and will be used to pay a dividend to the Company’s parent.

 

Upon consummation of the Hexion Combination, we will also enter into $775 million of new senior secured credit facilities. We will use proceeds from a portion of the borrowings under our new senior secured credit facilities, together with the proceeds of this Series A Preferred Stock offering, to pay a special dividend of approximately $550 million to our common stockholders. In addition, in connection with the Bakelite Acquisition we have borrowed $250 million under our bridge loan facility, which we expect to repay in full with the issuance of additional senior secured debt and available cash.

 

Capital Expenditures

 

As a combined entity, Hexion plans to spend approximately $120 on capital expenditures in 2005 and approximately $110 annually thereafter. Of the $110 anticipated future capital expenditures, we expect approximately $65 will be used for maintenance projects and approximately $45 for plans to continue increasing plant production capacity as necessary to meet demand and ROI projects. We plan to fund capital expenditures through operations and, if necessary, through available lines of credit.

 

Off-Balance Sheet Arrangements

 

We have no off-balance sheet arrangements.

 

Covenant Compliance

 

Adjusted EBITDA is used to determine compliance with the debt incurrence covenant contained in the indenture governing the Floating and Fixed Rate Notes. Because we are highly leveraged, our compliance with this covenant is important for the investors in the Company’s debt.

 

Adjusted EBITDA is defined as Net income adjusted to exclude depreciation and amortization, interest expense, non-operating income and expenses, unusual items and certain pro forma adjustments permitted in calculating covenant compliance under the indentures governing the notes and our Amended Credit Facility. We believe that the inclusion of supplemental adjustments to net income applied in presenting Adjusted EBITDA are appropriate to provide additional information to investors to demonstrate compliance with our financing covenants.

 

During the first quarter, we received a waiver of the dividend restriction under the HAI Facility for a dividend declared in the first quarter. As of March 31, 2005, we were in compliance with all material covenants contained in our indenture governing the notes and credit facilities.

 

34


Table of Contents

Reconciliation of Adjusted EBITDA to Net (Loss) Income

 

     Three months ended
March 31,


     2005

    2004

Net (loss) income

   $ (4,262 )   $ 4,914

Depreciation and amortization

     12,360       11,943

Adjustments to Segment EBITDA (see page 30)

     (67 )     2,102

Interest expense

     21,785       11,890

Other non-operating expense

     9,113       61

Income tax expense

     5,333       3,937
    


 

Segment EBITDA

     44,262       34,847

Adjusted EBITDA (a) (c):

              

Management fees

     625       837

Brazil reactor impact (b)

     (500 )     —  

Cost savings

     156       1,310

Benefit plan subsidy amendment

     —         375

Purchasing power savings

     —         1,625
    


 

Adjusted EBITDA

   $ 44,543     $ 38,994
    


 


(a) To arrive at Adjusted EBITDA, we are required to make adjustments to net income for management fees paid to our sponsors, unusual operating impacts and certain pro forma adjustments. These pro forma adjustments include the full year impact of completed acquisitions and approved amendments to our postretirement plan and cost and purchasing savings we expect to achieve.
(b) Amount represents the impact of the mechanical failure of a Brazilian reactor that occurred in the third quarter of 2004. The Company filed an insurance claim to recover substantially all losses related to this item and received an installment payment of $500 in the first quarter of 2005. In April 2005, the Company received the remaining $2,750 payable under the insurance claim.
(c) To incur additional debt under the Floating and Fixed Note indenture, a Fixed Charge Coverage Ratio of greater than 2 to 1 must be maintained. The Company’s ratio as of March 31, 2005 after giving effect to the acquisition and additional debt was 3.0 to 1.

 

Recent Accounting Pronouncements

 

None.

 

35


Table of Contents

ITEM 3: Quantitative and Qualitative Disclosures about Market Risk

 

There have been no material changes to the information on market risk reported in the Company’s Annual Report on Form 10-K at December 31, 2004.

 

ITEM 4: Controls and Procedures

 

  (a) Evaluation of Disclosures Controls and Procedures: As of the end of the period covered by this Quarterly Report on Form 10-Q, we carried out an evaluation, under the supervision and with the participation of our Disclosure Committee and our management, including our President and Chief Executive Officer and our Executive Vice President and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures pursuant to Exchange Act Rules 13a-15(e) and 15d-15(e). Based on that evaluation, the President and Chief Executive Officer and Executive Vice President and Chief Financial Officer concluded that our disclosure controls and procedures were effective to ensure that information we are required to disclose in reports that we file or submit under the Exchange Act are recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

 

  (b) Changes in Internal Controls: As a result of deficiencies identified by management in the income tax reporting process, the Company has engaged an international accounting firm to provide tax accounting and compliance services and to support current tax personnel. No other changes occurred in the Company’s internal control over financial reporting during the Company’s most recent fiscal quarter that materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

Part II

 

Item 1: Legal Proceedings

 

The Fayetteville, NC facility is negotiating a settlement with the North Carolina Department of Revenue and Natural Resources relating to alleged non-compliance with permitting requirements and air emission standards at that facility. At this time, we cannot be certain that the monetary sanctions associated with these allegations will not exceed $100,000.

 

Item 2: Unregistered Sales of Equity Securities and Use of Proceeds

 

There were no changes in securities during the first quarter of 2005.

 

Item 3: Defaults upon Senior Securities

 

There were no defaults on senior securities during the first quarter of 2005.

 

Item 4: Submission of Matters to a Vote of Security Holders

 

During the first quarter, our sole shareholder acted by written consent to approve our Restated Certificate of Incorporation.

 

Item 5: Other Information

 

Item 1.01. Entry into a Material Definitive Agreement

 

On May 11,2005 the Board of Directors of BHI Acquisition granted options to purchase shares of BHI Acquisition common stock to Messrs. Harris, Kleinman, and Seminara. Each director received options to purchase 60,566 shares at $2.89 per share. The options have a term of ten years and are automatically exercised upon the occurrence of an initial public offering of equity securities of the Company or of BHI Acquisition.

 

36


Table of Contents

Item 6: Exhibits

 

(10)

       Form of Non-Qualified Stock Option Agreement between BHI Acquisition Corp. and certain non-employee directors dated May 11, 2005.

(31)

       Rule 13a-14 Certifications
   

(a)

   Certificate of the Chief Executive Officer
   

(b)

   Certificate of the Chief Financial Officer

(32)

       Section 1350 Certifications

 

37


Table of Contents

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

    BORDEN CHEMICAL, INC.

Date: May 16, 2005

 

/s/ William H. Carter


    William H. Carter
    Executive Vice President and
    Chief Financial Officer
    (Principal Financial Officer)

 

38